Imagine investing in a company that not only leads in diabetes care with drugs like Ozempic but also has a revolutionary obesity treatment with Wegovy.
This thesis aims to determine the intrinsic value of Novo Nordisk, assessing whether it is undervalued, overvalued, or fairly valued.
Methodology: This valuation integrates multiple
